Wolverine+ (BPC-157 + TB-500 + MGF)
An extended recovery stack adding Mechano Growth Factor (MGF) to the BPC-157 + TB-500 blend, aiming to layer muscle-stem-cell activation onto tissue repair. All three components are animal/lab-level only, with no human or combination trials.
In plain English
'Wolverine+' takes the BPC-157 + TB-500 recovery blend and adds MGF (Mechano Growth Factor), a splice variant of IGF-1 studied for waking up muscle stem cells. The theory is to stack three repair mechanisms: blood-vessel growth (BPC-157), cell migration (TB-500), and satellite-cell activation (MGF). In practice, all three are studied almost entirely in animals and cell culture, none has human RCTs, none is FDA-approved, and both TB-500 and MGF are banned in sport by WADA. The combination has never been studied. This is an experimental stack assembled from preclinical components.
What it is
A three-peptide research combination: BPC-157 (gastric-derived pentadecapeptide), TB-500 (thymosin beta-4 fragment), and MGF (the IGF-1Ec / mechano growth factor C-terminal E-peptide). Sold as an advanced injury/muscle-recovery stack. None is an approved drug.
Mechanism (summary)
The stack is designed to engage three repair pathways at once: BPC-157's angiogenic and growth-factor effects, TB-500's actin-binding and cell-migration effects, and MGF's proposed activation of satellite (muscle stem) cells after mechanical loading. Each mechanism is drawn from animal/in-vitro work on the individual molecules; the combined effect is entirely theoretical and has not been tested.
Why people research it
- Muscle injury and post-training recovery
- Tendon, ligament, and soft-tissue repair
- Satellite-cell activation for muscle regeneration
- Layered 'maximum recovery' stacking in sport
Human evidence
No human trials exist for this three-component combination, and none of the components has well-powered human RCT evidence. BPC-157 and TB-500 are studied in rodents; MGF is studied in animals and cell culture, with at least one careful study finding no effect on muscle cells. The combination's human benefits are unproven, and two of the three components (TB-500, MGF) are WADA-prohibited.
Animal / lab evidence
Individually: BPC-157 accelerates tendon and gut healing in rats; thymosin beta-4 / TB-500 supports wound healing and cardiac repair in animals; MGF is associated with satellite-cell activation after muscle damage in rodents, though in-vitro results are contradictory. No animal study evaluates the three together; the rationale is assembled from the separate literatures.
Key studies
Each summary explains the design, what was found, and what it doesn't prove.
Animal tendon-healing evidence for one of the three components only.
Animal repair evidence for the TB-500 component; says nothing about the three-peptide stack.
Animal evidence for the MGF component's repair signaling. It does not validate injecting MGF, let alone the full stack.
History
An escalation of the 'Wolverine' stack, vendors added MGF to BPC-157 + TB-500 to market a more aggressive recovery and muscle-regeneration blend, again without any combination or human evidence behind the claim.
PeptidePedia is for educational and informational purposes only. We do not sell peptides, prescribe peptides, provide medical advice, or recommend treatment. Peptides may not be approved for human use except in specific legal prescription or clinical contexts. Always consult a licensed medical professional before making health decisions.
Related peptides
A 15-amino-acid fragment derived from a stomach-protecting protein, widely studied in rodents for gut, tendon, and ligament repair.
A synthetic fragment of thymosin beta-4 studied in animals for wound healing, cardiac repair, and tissue regeneration.
Mechano Growth Factor (MGF) is a locally-acting splice variant of IGF-1 (IGF-1Ec) studied for its proposed role in activating muscle stem cells and triggering early muscle repair after mechanical loading. Evidence is almost entirely animal and cell-culture based, with no human therapeutic trials.